1 recruiting, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
Follow hydroxycamptothecinum: new trials by email Literature Review of hydroxycamptothecinum trials Research Report on hydroxycamptothecinum
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC SHR-1501 for Injection, BCG for Injection, Epirubicin Hydrochloride for Injection - NMIBC | Phase 3 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 236 | 2026-07-13 | 2026-07-20 |
| Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma liver resection, transarterial chemoembolization, carboplatin - Hepatocellular Carcinoma | Phase 3 | Unknown | Sun Yat-sen University | 198 | 2014-03-01 | 2016-04-28 |
Carcinoma, Hepatocellular (1) · Non-Muscle Invasive Bladder Neoplasms (1)
Sun Yat-sen University (1) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. (1)
China (2)